6533b862fe1ef96bd12c74a4

RESEARCH PRODUCT

Klinische Bedeutung des Hepatitis-B-Virus-DNS-Nachweises im Serum von Kindern mit chronischer Hepatitis B

U. SchwarzeBernhard ZabelE. SchaeferStefan WirthU. Möllers

subject

HBEAG POSITIVEbusiness.industryvirus diseasesDot blotElevated liver enzymesClose relativesVirologydigestive system diseaseslaw.inventionVaccinationHBeAgViral replicationlawmental disordersPediatrics Perinatology and Child HealthImmunologyMedicinebusinessPolymerase chain reaction

description

206 sera from 172 children with chronic hepatitis B infection were tested for HBV DNA by dot blot hybridization. 111 were positive and 95 negative for HBV DNA. 103 (78.6%) of the positive patients had HBeAg and 5 (7.7%) anti-HBe. In 60 (92.3%) of the anti-HBe positive sera no HBV DNA could be detected. Children with elevated liver enzymes had HBV DNA in 80.1%, whereas in 71.6% of the chronic HBsAg carriers with normal liver enzymes no HBV DNA was found. In 87 of the 95 dot blot negative patients polymerase chain reaction was performed. 73 (83.9%) children of this group were HBV DNA positive. All HBeAg positive patients and those with elevated aminotransferases had HBV DNA in their serum. 56 anti-HBe-positive HBsAg carriers were also positive; 14 were negative for HBV DNA. Our results demonstrate that viral sequences can be found in all HBeAg positive and in most of the anti-HBe positive children. Patients with ongoing virus replication have to be considered infectious and recommendation for vaccination of close relatives of these patients must be stressed.

https://doi.org/10.1055/s-2007-1025342